Healthwarehouse.Com (HEWA) 0.1175

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthwarehouse.Com (HEWA) 0.1175 $HEWA

HealthWarehouse.com and RxREVU Partner to Provide Drug Price Transparency to Consumers
Filing Services Canada XHTML - Thu Jun 11, 7:30AM CDT


HealthWarehouse.com to Present at the 2015 Marcum MicroCap Conference
Filing Services Canada - Tue May 26, 3:16PM CDT
HealthWarehouse.com to Present at the 2015 Marcum MicroCap Conference CINCINNATI, OH (FSCwire) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced today that it will present at the 2015 Marcum MicroCap Conference on Wednesday, May 27, 2015 in New York City at the Grand Hyatt Hotel. The Company's presentation by Lalit Dhadphale, President & CEO, is scheduled to begin at 4:00 p.m. ET. The annual Marcum MicroCap Conference is a showcase for public companies with less than $500 million in market capitalization. For more information or to register, please visit the conference website athttp://www.marcumllp.com/microcap (http://www.marcumllp.com/microcap). About HealthWarehouse.com HealthWarehouse.com, Inc. (OTCQB:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the growing out of pocket prescription market, which is expected to grow to $80 billion in 2015. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, HealthWarehouse.com has become the largest VIPPS accredited online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit HealthWarehouse.com online at http://www.HealthWarehouse.com (http://us.lrd.yahoo.com/SIG=11jgvkj9s/EXP=1313683171/**http%3A/www.healthwarehouse.com/). About the Marcum MicroCap Conference The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies under$500 millionin market capitalization can network with the investment community. The conference features presentations by CEOs and CFOs from six principal industry sectors and provides investors with the opportunity to meet with management of these companies on a one-on-one basis. Industry sectors include Technology, Media & Internet; Software & Business Services; Life Science & Healthcare; Retail & Consumer Products; Energy & Natural Resources; and Industrials. The conference additionally includes a full agenda of panel discussions on issues of strategic importance to small cap issuers and investors, moderated by industry leaders. The Marcum MicroCap Conference attracts fund managers and high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, includingsenior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace. For complete information about the 2015 Marcum MicroCap Conference, visitwww.marcumllp.com/microcap. (http://www.marcumllp.com/microcap) Marcum is a registered Public Company Accounting Oversight Board (PCAOB) firm. Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. Marcum's SEC Practice led the audit industry in most net new public company clients in the fourth quarter of 2013. For more information, visitwww.marcumllp.com (http://www.marcumllp.com/). About Marcum LLP Marcum LLP is one of the largest independent public accounting and advisory services firms inthe United States. Ranked #15 nationally, Marcum LLP offers the resources of 1,300 professionals, including over 160 partners, in 23 offices throughout the U.S.,Grand CaymanandChina. Headquartered inNew York City, the Firm's presence runs deep, with full-service offices strategically located in major business markets. Marcum is a member of theMarcum Group (http://www.marcumgroup.com/), an organization providing a comprehensive range of professional services spanning accounting and advisory, technology solutions, wealth management, and executive and professional recruiting. The Marcum Group companies includeMarcum LLP (http://www.marcumllp.com/);Marcum Technology LLC (http://www.marcumtechnology.com/);Marcum Search LLC (http://www.marcumsearch.com/);Marcum Financial Services LLC (http://www.marcumfs.com/);Marcum Bernstein & Pinchuk LLP (http://www.marcumbp.com/); andMarcumBuchanan Associates LLC (http://www.marcumbuchanan.com/). Contact Mr. Lalit Dhadphale, CEO lalit@healthwarehouse.com (859) 444-7341 To view this press release as a PDF file, click onto the following link: http://fscwire.com/sites/default/files/news_r...262015.pdf Source: HealthWarehouse.com Inc. (OTCQB:HEWA) http://www.healthwarehouse.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.

HealthWarehouse.com Reports 9.3% Sales Growth Quarter over Quarter
Filing Services Canada - Thu May 14, 7:00AM CDT
HealthWarehouse.com Reports 9.3% Sales Growth Quarter over Quarter Net Loss Narrows by 65.6% While Gross Margin Remains Steady at 61% Cincinnati, Ohio (FSCwire) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the quarter ended March 31, 2015. For the quarter ended March 31, 2015, net sales improved to $1,612,676 up 9.3% from the prior quarter ended December 31, 2014. Gross margin remained steady at 61% while net loss narrowed by 65.6% to ($200,788) from the quarter ended March 31, 2015 from ($582,340) for the quarter ended December 31, 2014. For the quarter ended March 31, 2015, HEWA reported adjusted EBITDAS of ($65,406), vs. adjusted EBITDAS of ($392,436) for the quarter ended December 31, 2014, an improvement of 82.9%. The Company believes that adjusted EBITDAS (Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation), a non-GAAP financial measure, is useful in evaluating its operating performance compared to that of other companies in our industry. Our renewed focus to serve online consumers who pay out of pocket for their prescriptions has begun to show gains financially with core online prescription and over-the-counter (OTC) revenue growth and significantly reduced net losses. Moreover, evidence that we are providing a valuable service is shared daily in our customer reviews, said Mr. Lalit Dhadphale, President & CEO of HealthWarehouse.com. A customer recently shared the following review, These guys are awesome! I've been dealing with HealthWarehouse.com for a good many years and have never been anything but satisfied. I take quite a bit of medication and their prices for generics have been even lower than my copay with my insurance when I had been working. Now that I'm on Medicare, I have a Part D plan for medication. Some generic drugs I take aren't even covered by the plan. So, I get them through HealthWarehouse.com. Reasonable prices, quick delivery, exceptional customer service. 1st Quarter 2015 Highlights: Â?[[44]] Net Sales: Increased by $137,421 or 9.3% compared to the 4th Quarter of 2014, due to increased advertising activity, specifically with Google. Â?[[44]] Gross Profit: Increased by $75,498 or 8.3% compared to the 4th Quarter of 2014 due to the sales growth while holding margins steady at 61% . Â?[[44]] SG&A Expenses: Declined by $576,756 or 34.2% compared to the 4th Quarter of 2014, primarily due to reductions in stock based compensation, litigation settlement and legal expenses. Â?[[44]] Net Loss: Declined by $381,552 or 65.5% compared to the 4th Quarter of 2014 as a result of the increased net sales and reduced operating expenses as detailed above. About HealthWarehouse.com HealthWarehouse.com, Inc. (OTCQB:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the growing out of pocket prescription market, which is expected to grow to $80 billion in 2015. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, HealthWarehouse.com has become the largest VIPPS accredited online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit HealthWarehouse.com online at http://www.HealthWarehouse.com (http://us.lrd.yahoo.com/SIG=11jgvkj9s/EXP=1313683171/**http%3A/www.healthwarehouse.com/). Forward-Looking Statements This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, payments and fraud. More information about factors that potentially could affect HealthWarehouse.com (http://healthwarehouse.com/)'s financial results is included in HealthWarehouse.com (http://healthwarehouse.com/)'s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings. Use of Non-GAAP Measures HealthWarehouse.com (http://healthwarehouse.com/), Inc. (the "Company" prepares its consolidated financial statements in accordance with the United States generally accepted accounting principles ("U.S. GAAP" . In addition to disclosing financial results prepared in accordance with U.S. GAAP, the Company discloses information regarding adjusted EBITDAS, which differs from the term EBITDA as it is commonly used. In addition to adjusting operating loss to exclude interest, depreciation and amortization, adjusted EBITDAS also excludes stock issued for services, and certain other non-cash charges. Adjusted EBITDAS is not a measure of performance defined in accordance with U.S. GAAP. However, adjusted EBITDAS is used internally in planning and evaluating the Company`s performance. Accordingly, management believes that disclosure of this metric offers investors, bankers and other shareholders an additional view of the Company`s operations that, when coupled with the GAAP results, provides a more complete understanding of the Companys financial results. Adjusted EBITDAS should not be considered as an alternative to net loss or to net cash used in operating activities as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company`s performance. A reconciliation of U.S. GAAP net loss to adjusted EBITDAS is included in the accompanying financial schedules. Contact Mr. Lalit Dhadphale, CEO lalit@healthwarehouse.com (859) 444-7341 To view this press release as a PDF file, click onto the following link: http://fscwire.com/sites/default/files/news_r...142015.pdf Source: HealthWarehouse.com Inc. (OTCQB:HEWA) http://www.healthwarehouse.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.

HealthWarehouse.com Reports 2014 Annual Results
Filing Services Canada - Thu Apr 02, 7:32AM CDT
HealthWarehouse.com Reports 2014 Annual Results Cincinnati, Ohio (FSCwire) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the year ended December 31, 2014. For the year ended December 31, 2014, gross margin improved to 59.3%, up from 50.0%, while net loss narrowed by 67.5%, to ($1,783,279) from ($5,489,892). Net sales were $6,129,660 for the year ended December 31, 2014, a 40.1% decrease from the comparable period in 2013, as the Company shed non-profitable business relations in 2014 to focus on the higher margin out of pocket cash prescription market. For the year ended December 31, 2014, HEWA reported adjusted EBITDAS of ($596,594), vs. adjusted EBITDAS of ($870,207) in the year ended December 31, 2013, an improvement of 31.4%. The Company believes that Adjusted EBITDAS (Earnings Before Interest, Taxes, Depreciation, Amortization and Stock-Based Compensation), a non-GAAP financial measure, is useful in evaluating its operating performance compared to that of other companies in our industry. Mr. Lalit Dhadphale, HealthWarehouse.coms President and CEO, commented, In order to position our Company for sustainable and profitable growth, we made the decision to focus our business efforts on the growing out of pocket prescription market and wind down other non-profitable business relations in late 2013 and 2014. With continued pressures on employers to contain healthcare costs, consumers are assuming higher co-pays and deductibles, and paying more upfront out of pocket expenses for their prescriptions. This opportunity in the cash prescription market has never been greater. While this transition negatively impacted revenue growth, we continue to realize improved gross margins and operating efficiencies from the implementation of our 2013/2014 initiatives as operating losses continue to shrink. With these right-sizing measures in place and the completion of the capital raise in the second half of last year, we are turning our attention toward renewing revenue growth through new marketing initiatives and improved customer experience with improvements to our website. The combination of top line growth and improved operating margins should position us for profitable growth going forward. 2014 Highlights: Â?[[44]] Timely filing of all Quarterly and Annual Reports with the Securities & Exchange Commission Â?[[44]] Equity Raise: Completed private equity raise of approximately $1.65 million, September 2014 Â?[[44]] Senior Debt: Renewal of Senior Debt for six months to September 2015, with ability to extend maturity date to March 2016 by meeting certain financial requirements Â?[[44]] Inventory: Reduced inventory by 48% or $133,000 Â?[[44]] Accounts Receivable: Reduced accounts receivable by 67% or $206,000 Â?[[44]] Accounts Payable: Including settlements, reduced accounts payable by 23% or $767,000 Â?[[44]] Average Quarterly RX fill time: Improved to 3.2 days from 3.9 days Â?[[44]] Average Quarterly OTC fill time: Improved to 1.8 days from 11.9 days Â?[[44]] Relaunch of Website: Relaunched website with responsive design for mobile devices 2014 Details: Â?[[44]] Net Sales: Declined by 40.1% compared to 2013, due to the reduction in business-to-business sales and cash flow constraints. Due to cash flow constraints, the Company was unable to consistently expand its advertising efforts to grow its core online prescription business and was not able to maintain over-the-counter inventories to satisfy incoming orders. Â?[[44]] Gross Margin: Increased from 50.0% in 2013 to 59.3%, primarily due to improvement in the Companys costs associated with improved vendor purchasing agreements, the elimination of unprofitable business relations, the reduction of lower-margin business-to-business sales relative to total sales and efforts to improve profitability across the entire product line. Â?[[44]] SG&A Expenses: Declined by 28.9% compared to 2013, primarily due to reductions in legal, salary and contract labor related to warrants issued, freight and health benefits expenses. Â?[[44]] Net Loss: Declined by 67.5% compared to 2013 as a result of the increased profit margins and reduced operating expenses as detailed above. About HealthWarehouse.com HealthWarehouse.com, Inc. (OTCQB:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the growing out of pocket prescription market, which is expected to grow to $80 billion in 2015. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, HealthWarehouse.com has become the largest VIPPS accredited online pharmacy in the United States. HealthWarehouse.com is licensed in all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit HealthWarehouse.com online at http://www.HealthWarehouse.com (http://us.lrd.yahoo.com/SIG=11jgvkj9s/EXP=1313683171/**http%3A/www.healthwarehouse.com/). Forward-Looking Statements This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, payments and fraud. More information about factors that potentially could affect HealthWarehouse.com (http://healthwarehouse.com/)'s financial results is included in HealthWarehouse.com (http://healthwarehouse.com/)'s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings. Use of Non-GAAP Measures HealthWarehouse.com (http://healthwarehouse.com/), Inc. (the "Company" prepares its consolidated financial statements in accordance with the United States generally accepted accounting principles ("U.S. GAAP" . In addition to disclosing financial results prepared in accordance with U.S. GAAP, the Company discloses information regarding adjusted EBITDAS, which differs from the term EBITDA as it is commonly used. In addition to adjusting operating loss to exclude interest, depreciation and amortization, adjusted EBITDAS also excludes stock issued for services, and certain other non-cash charges. Adjusted EBITDAS is not a measure of performance defined in accordance with U.S. GAAP. However, adjusted EBITDAS is used internally in planning and evaluating the Company`s performance. Accordingly, management believes that disclosure of this metric offers investors, bankers and other shareholders an additional view of the Company`s operations that, when coupled with the GAAP results, provides a more complete understanding of the Companys financial results. Adjusted EBITDAS should not be considered as an alternative to net loss or to net cash used in operating activities as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company`s performance. A reconciliation of U.S. GAAP net loss to adjusted EBITDAS is included in the accompanying financial schedules. Contact HealthWarehouse.com Mr. Lalit Dhadphale, CEO (859) 444-7341 To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...202015.pdf Source: HealthWarehouse.com Inc. (OTCQB:HEWA) http://www.healthwarehouse.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.

HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital
Filing Services Canada XHTML - Wed Mar 18, 8:00AM CDT


HealthWarehouse.com Responds to Senator Klobuchar & McCain on Reintroduction of Canadian Pharmacy Bill
Filing Services Canada XHTML - Tue Jan 27, 7:33AM CST


HealthWarehouse.com Relaunches Website for Consumers Who Pay Out of Pocket for Prescriptions
Filing Services Canada XHTML - Wed Jan 07, 8:08AM CST


HealthWarehouse.com Reports Third Quarter 2014 Results
Filing Services Canada XHTML - Mon Nov 24, 7:02AM CST


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 328

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading